New - European Medical Journal

Continue

News

Cardiology
13 Jun 2017

Acarix Receives First Commercial Order for CADScor®System for Early Detection of Coronary Artery Disease from Danish Hospital

Malmö, Sweden, 13 June, 2017 – Acarix AB (publ) (“Acarix” or the “Company”) today announced that Herning Hospital has placed the first commercial order…
Diabetes
13 Jun 2017

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

New LEADER analysis shows Victoza® reduces cardiovascular risk in people with Type 2 Diabetes regardless of severe hypoglycaemia events.
Oncology
13 Jun 2017

PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers

PharmaMar announces encouraging results in clinical trials of Lurbinectedin in endometrial and breast cancers. Find out more
Nephrology
12 Jun 2017

New Biomarker in Renal Replacement Therapy

SURVIVAL in patients undergoing renal replacement therapy could be improved by the utilisation of biomarker measurements, according to the results of a…
Nephrology
12 Jun 2017

Stereotactic Ablative Radiation Therapy: A Better Alternative to Conventional Therapy?

TREATMENT of metastatic kidney cancer using a focussed therapy known as stereotactic ablative radiation has been shown to result in >90% control of…
Urology
8 Jun 2017

Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga…
Hepatology
8 Jun 2017

Introducing EMJ Hepatology 5.1

United Kingdom, June 08, 2017: Welcome to the latest edition of our EMJ Hepatology eJournal! This issue is jam-packed with the latest hepatological…
Oncology
6 Jun 2017

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

Oxford, UK and Conshohocken, US, 5 June, 2017 – Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer…